Nasogen Menthol (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Nasogen Menthol, is an alpha‑adrenergic agonist presented as a nasal spray for nasal use. It relieves nasal congestion associated with the common cold, sinusitis and allergic rhinitis in adults and children and provides rapid improvement of airflow.

GNH USA supplies Nasogen Menthol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures reliable delivery and compliance with global quality standards.

Xylometazoline is an alpha‑adrenergic agonist used to relieve nasal congestion in several upper‑respiratory conditions.

Common cold (nasal congestion): reduces swelling of nasal mucosa, improving airflow. Sinusitis: alleviates blockage of sinus passages, facilitating drainage. Allergic rhinitis: diminishes nasal obstruction caused by allergic inflammation.

Xylometazoline may cause local and systemic adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal burning or stinging sensation - Nasal dryness or crusting - Sneezing - Headache

Serious or Rare Side Effects: - Rebound nasal congestion (rhinitis medicamentosa) with prolonged use - Nosebleeds (epistaxis) - Severe hypertension (very rare) - Allergic skin reaction

Before using Nasogen Menthol, consider the following precautions to ensure safe and effective treatment.

Age limitation: Use in children under 6 years: not recommended unless advised by a healthcare professional. Duration of use: Maximum duration: limit use to three consecutive days to avoid rebound congestion. Pregnancy and lactation: Safety in pregnancy or breastfeeding: consult a physician; data are limited. Existing nasal conditions: Severe nasal septum deviation or ulceration: avoid use or seek medical advice. Concomitant vasoconstrictors: Avoid using with other nasal decongestants or systemic sympathomimetics to prevent excessive vasoconstriction. Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Xylometazoline can interact with certain medicines; awareness of these interactions helps prevent adverse effects.

Major Interactions (Avoid): - Other nasal decongestants: Concurrent use with other topical nasal decongestants may cause excessive vasoconstriction and hypertension. - Monoamine oxidase inhibitors (MAOIs): Combined with MAOIs, systemic absorption could potentiate sympathomimetic effects, increasing blood pressure.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: May reduce the effectiveness of oral antihypertensives, requiring blood pressure monitoring. - Beta‑blockers: Potential additive cardiovascular effects; monitor for bradycardia or hypotension. - Oral decongestants (pseudoephedrine): Combined systemic decongestant effect may increase risk of cardiovascular side effects.